Research
Citi Upgrades Sumitomo Pharma to Neutral from Sell; Price Target is 1,500 Yen
Sumitomo Pharma (TYO:4506) has an average rating of overweight and mean price target of 2,128.57 yen, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
TYO:4506
